Drospirenone promotes apoptosis in ectopic but inhibits proliferation in eutopic human endometrial stromal cells
PLOS One · 2026
DOI: 10.1371/journal.pone.0341590 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Thanyarat Wongwananuruk und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gynecologic Endocrinology Unit, Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mah…. Hauptthemen laut MEDLINE: Androstenes, Apoptosis, Cell Proliferation, Stromal Cells. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medicine Siriraj Hospital, Mahidol University.
Abstract (Originalsprache)
Background
Endometriosis is a complex gynecological condition characterized by endometrial tissue growing outside the uterus. In many in vitro studies, almost all progestins have indicated the anti-proliferation and apoptosis of endometriotic stromal cells. Drospirenone, a synthetic progestin structurally distinct from traditional progestins, still lacks sufficient data regarding its effects on endometriosis, particularly in terms of antiproliferative and pro-apoptotic activity. This study investigates the antiproliferative effects of drospirenone on eutopic (EU-ESCs) and ectopic human endometrial stromal cells (EC-ESCs), and compare its impact on apoptotic effects in both cell types. Methods and Findings In the study, paired EU-ESCs and EC-ESCs were obtained from patients diagnosed with endometriosis (n = 12). EU-ESCs and EC-ESCs were treated with and without drospirenone. Antiproliferative markers and apoptotic markers were evaluated and compared between the two groups. Interestingly, drospirenone at a concentration of 1 µM significantly affected cell viability in both EU-ESCs and EC-ESCs. In EU-ESCs, Ki-67 expression was significantly reduced compared to controls (0.17 vs. 1; p = 0.003), while in EC-ESCs, the reduction was not statistically significant. Caspase-3 expression was significantly increased in both EU-ESCs (1.13 vs. 1) and EC-ESCs (1.57 vs. 1) (p= 0.02 and p = 0.05, respectively). Additionally, BCL2 expression decreased in both cell types following treatment. BAX expression increased in both EU-ESCs and EC-ESCs. Expression levels of PTEN and P53 also increased in both cell types, with statistical significance observed only in EC-ESCs (p = 0.03 and p = 0.04, respectively). BAK expression decreased in EU-ESCs but increased in EC-ESCs compared to controls.
Conclusions
Drospirenone exhibits an antiproliferative effect on EU-ESCs and induces a more pronounced apoptotic response in EC-ESCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Gynecologic Endocrinology Unit, Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
- Center of Reproductive Genetics and Stem cell Biology, Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
- Department of Obstetrics and Gynecology, Thammasat University, Bangkok, Thailand.
ORCID-Profile: Somsin Petyim
Förderung
- Faculty of Medicine Siriraj Hospital, Mahidol University
Zitieren
APA
Wongwananuruk, T., Petyim, S., Suwannalert, P., Tungprasertpol, K., & Klaymook, S. (2026). Drospirenone promotes apoptosis in ectopic but inhibits proliferation in eutopic human endometrial stromal cells. PLOS One. https://doi.org/10.1371/journal.pone.0341590
Vancouver
Wongwananuruk T, Petyim S, Suwannalert P, Tungprasertpol K, Klaymook S. Drospirenone promotes apoptosis in ectopic but inhibits proliferation in eutopic human endometrial stromal cells. PLOS One. 2026. doi:10.1371/journal.pone.0341590
BibTeX
@article{Wongwananuruk2026,
author = {Wongwananuruk, Thanyarat and Petyim, Somsin and Suwannalert, Pawitra and Tungprasertpol, Kittima and Klaymook, Supatra},
title = {Drospirenone promotes apoptosis in ectopic but inhibits proliferation in eutopic human endometrial stromal cells},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0341590}
}
EUVIMED